ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 556 filers reported holding ASTRAZENECA PLC in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,312,029 | -9.7% | 34,141 | -4.6% | 0.10% | +6.5% |
| Q2 2023 | $2,561,490 | -2.9% | 35,790 | -5.8% | 0.09% | -9.8% |
| Q1 2023 | $2,637,580 | +12.0% | 38,000 | +9.4% | 0.10% | +3.0% |
| Q4 2022 | $2,355,440 | +31.1% | 34,741 | +6.0% | 0.10% | +22.2% |
| Q3 2022 | $1,796,000 | +95.0% | 32,765 | +134.8% | 0.08% | +97.6% |
| Q2 2022 | $921,000 | +4.2% | 13,953 | +4.6% | 0.04% | +17.1% |
| Q1 2022 | $884,000 | +186.1% | 13,334 | +151.3% | 0.04% | +118.8% |
| Q4 2021 | $309,000 | -49.0% | 5,305 | -47.6% | 0.02% | -46.7% |
| Q2 2021 | $606,428 | +49.0% | 10,124 | +23.6% | 0.03% | +30.4% |
| Q1 2021 | $407,107 | +14.5% | 8,188 | +15.1% | 0.02% | 0.0% |
| Q4 2020 | $355,629 | +4.5% | 7,114 | +14.6% | 0.02% | -14.8% |
| Q3 2020 | $340,164 | -23.8% | 6,207 | -26.5% | 0.03% | -28.9% |
| Q2 2020 | $446,529 | +20.3% | 8,443 | +1.5% | 0.04% | -5.0% |
| Q1 2020 | $371,330 | +7.2% | 8,315 | +19.7% | 0.04% | +33.3% |
| Q4 2019 | $346,466 | +6.1% | 6,949 | -5.1% | 0.03% | -3.2% |
| Q3 2019 | $326,510 | +6.1% | 7,326 | -97.1% | 0.03% | +10.7% |
| Q2 2019 | $307,733 | +3.4% | 250,000 | +3295.8% | 0.03% | -12.5% |
| Q1 2019 | $297,659 | -8.0% | 7,362 | -13.6% | 0.03% | -23.8% |
| Q4 2018 | $323,665 | -3.0% | 8,522 | +1.0% | 0.04% | +10.5% |
| Q3 2018 | $333,772 | +54.2% | 8,434 | +36.8% | 0.04% | +35.7% |
| Q2 2018 | $216,492 | -3.3% | 6,166 | -3.7% | 0.03% | -15.2% |
| Q1 2018 | $223,877 | -22.9% | 6,402 | -23.5% | 0.03% | -21.4% |
| Q4 2017 | $290,357 | -46.6% | 8,368 | -47.9% | 0.04% | -52.3% |
| Q3 2017 | $543,757 | -11.1% | 16,050 | -10.5% | 0.09% | -23.5% |
| Q2 2017 | $611,477 | +8.3% | 17,937 | -1.1% | 0.12% | -7.3% |
| Q1 2017 | $564,759 | +6.9% | 18,136 | -6.2% | 0.12% | -6.8% |
| Q4 2016 | $528,328 | -20.7% | 19,339 | -4.6% | 0.13% | -26.1% |
| Q3 2016 | $666,122 | +103.3% | 20,272 | +86.8% | 0.18% | +81.8% |
| Q2 2016 | $327,701 | – | 10,855 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |